ONCOSYNE AS

926191942AksjeselskapMVA
Municipality
OSLO
Founded
30.11.2020
Roles
5
Company details
Business address
Ullernchausséen 64, 0379 OSLO
Municipality
Oslo
Sector
Private aksjeselskaper mv.
Share capital
1 124 801 kr(1 124 801 shares)
Registered
16.12.2020
Purpose
Forskning og utviklingsarbeid innen medisinsk bioteknologi med det formål å tilby legemiddelscreening som en diagnostisk tjeneste. Legemiddelscreenen skal være et beslutningsverktøy for skånsom, presis og effektiv kreftbehandling.
Board and management

Styre og ledelse

Regnskapsfører

AIDER AS

Is regnskapsfører for 14 668 companies

Regnskapsfører

Relationship graph

Explore in 3D
Loading graph...
Click a node to navigate. Drag to move. Company PersonStyreDaglig lederRevisorRegnskapInnehaverOpen in 3D →
Financials2024
Revenue
4.4 mill
Operating result
-2.0 mill
Net result
-1.7 mill
Assets
12.0 mill
Equity
10.8 mill
Debt
1.2 mill
Financial health check
Equity ratio
Very good
Current ratio
Very good
Profitability
Weak
Income statement and balance sheet
2024
Income statement
Revenue4.4 mill
Operating costs6.4 mill
= Operating result-2.0 mill
Net finance260k
= Net result-1.7 mill
Balance sheet
Fixed assets857k
Current assets11.1 mill
= Total assets12.0 mill
Equity10.8 mill
Long-term debt0
Short-term debt1.2 mill
= Total debt1.2 mill

Source: Brønnøysund Register Centre

Key Ratios
2024Industry (median)
Operating margin
-45.2%-3.7%
Net margin
-39.3%
Return on assets
-14.4%-0.2%
Return on equity
-16.0%
Equity ratio
90.0%50.7%
Current ratio
9.241.90
Debt-to-equity
0.110.62

Based on 648 companies

Source: Brønnøysund Register Centre. Ratios are calculated using universal formulas.

Powered by Webagent — digital solutions for Norwegian businesses

Powered by Webagent